HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yafang Qian Selected Research

valtrate

5/2021Valtrate as a novel therapeutic agent exhibits potent anti-pancreatic cancer activity by inhibiting Stat3 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yafang Qian Research Topics

Disease

2Neoplasms (Cancer)
05/2022 - 05/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
05/2021 - 09/2016
2Insulin Resistance
12/2012 - 01/2012
1Glioma (Gliomas)
05/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2017
1Chronic Renal Insufficiency
03/2017
1Abdominal Obesity
12/2012

Drug/Important Bio-Agent (IBA)

2Triglycerides (Triacylglycerol)IBA
03/2017 - 01/2012
2oxidized low density lipoproteinIBA
03/2017 - 12/2012
2Glucose (Dextrose)FDA LinkGeneric
03/2017 - 01/2012
2LDL CholesterolIBA
03/2017 - 12/2012
1Temozolomide (Temodar)FDA LinkGeneric
05/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2022
1valtrateIBA
05/2021
1EstersIBA
05/2021
1IridoidsIBA
05/2021
1CreatinineIBA
03/2017
1C-Reactive ProteinIBA
03/2017
1Cystatin CIBA
03/2017
1EmulsionsIBA
09/2016
1GemcitabineFDA Link
09/2016
1Apolipoprotein A-I (Apolipoprotein A1)IBA
12/2012
1ApolipoproteinsIBA
12/2012
1Apolipoproteins B (ApoB)IBA
12/2012
1HDL CholesterolIBA
01/2012